2 resultados para Stearate

em Deakin Research Online - Australia


Relevância:

20.00% 20.00%

Publicador:

Resumo:

In this study, shell powder was modified by sodium stearate surface modifier for improving the compatibility of SP with polymer materials. The surface modifiers influence on the physical and chemical properties of SP were studied by scanning electron microscope(SEM), fourier infrared spectrum(FT-IR), surface contact angle meter, XRD diffraction analysis meter and other modern instruments and analysis method. The results showed that the surface modifier was successfully coupled to the shell powder surface. After surface modifier modification, the interfacial compatibility of the shell powder with polymer materials was effectively improved. The contact angle of shell powder surface increased from 73.5 ° to 110.8 °, along with the dosage of sodium stearate surface modifier was 4.0%. All results suggested that modified shell powder is promising for using as a reinforcement filler in polymer materials. © (2014) Trans Tech Publications, Switzerland.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Corticosteroid receptor modulation of mesoaccumbens dopamine neurotransmission is believed to be a key neurobiological mechanism mediating the effects of stress in addiction. Importantly, nucleus accumbens (NAc) subregions (core and shell) are reported to respond differentially to fluctuating basal levels of glucocorticoids, with dopaminergic responses in the core of the NAc being somewhat impervious to fluctuating levels of glucocorticoids relative to the shell. To investigate the corticosteroid receptor mechanisms mediating basal dopamine efflux in the core of the NAc, we have used chronoamperometry in combination with stearate-modified graphite paste electrodes in urethane anesthetized male Long–Evans rats during the peak and nadir of the circadian cycle. Blockade of ventral tegmental area low-affinity glucocorticoid (GR) or high-affinity mineralocorticoid (MR) receptors with mifepristone (1 μg/μl) or spironolactone (0.2 μg/μl), respectively, indicated that endogenous phase-dependent corticosteroid receptor activation (GRs during peak; MRs during nadir) facilitated extracellular NAc dopamine efflux. Conversely, the alternate receptor's actions appeared inhibitory at these time points (MRs during peak; GRs during nadir). Pharmacological activation of either the GR or MR with corticosterone (2 μg/μl) or aldosterone (0.2 μg/μl), respectively, potentiated NAc dopamine efflux, irrespective of circadian phase. Together, these data suggest that dominant corticosteroid receptor activation stimulates tonic mesoaccumbens dopamine transmission, enabling MRs and GRs to differentially maintain basal NAc dopamine release over the course of the circadian cycle. This points to an important molecular mechanism through which relatively stable NAc core dopamine extracellular levels could be maintained in the face of fluctuating corticosterone circadian rhythms.